APO Research
Talk to an analyst

APO RESEARCH · REPORT

Helicobacter Pylori Infection Treatment

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Helicobacter Pylori Infection Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

4 July 2026191 pages

Choose your research edition.

Industry ResearchHelicobacter Pylori Infection Treatment Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Helicobacter Pylori Infection Treatment Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Helicobacter Pylori Infection Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Helicobacter Pylori Infection Treatment Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Helicobacter Pylori Infection Treatment Market Analysis and Forecast 2026-2032172 pages · $4,950 USD

Market perspective

The global Helicobacter Pylori Infection Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Helicobacter Pylori Infection Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Helicobacter Pylori Infection Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Helicobacter Pylori Infection Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Helicobacter Pylori Infection Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Helicobacter Pylori Infection Treatment include Cumberland Pharmaceuticals, Eisai Co., Bio-Rad Laboratories, F. Hoffmann-La Roche, Alpha Laboratories, Biohit, Phathom Pharmaceuticals, Redhill Biopharma and Takeda Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Helicobacter Pylori Infection Treatment market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Helicobacter Pylori Infection Treatment and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Helicobacter Pylori Infection Treatment revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Helicobacter Pylori Infection Treatment market size, projected growth trends, production technologies, key applications, and end-use industries.

Helicobacter Pylori Infection Treatment Segment by Company

Cumberland Pharmaceuticals

Eisai Co.

Bio-Rad Laboratories

F. Hoffmann-La Roche

Alpha Laboratories

Biohit

Phathom Pharmaceuticals

Redhill Biopharma

Takeda Pharmaceuticals

AbbVie

Helicobacter Pylori Infection Treatment Segment by Type

Bismuth-quadruple Therapy

Concomitant Therapy

Levofloxacin Triple Therapy

Bismuth Therapy

High-dose Dual Therapy

Helicobacter Pylori Infection Treatment Segment by Application

Hospitals

Diagnostics Laboratories

Clinics

Helicobacter Pylori Infection Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Helicobacter Pylori Infection Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Helicobacter Pylori Infection Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Helicobacter Pylori Infection Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Helicobacter Pylori Infection Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Helicobacter Pylori Infection Treatment industry.

Chapter 3: Detailed analysis of Helicobacter Pylori Infection Treatment companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Helicobacter Pylori Infection Treatmentrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Helicobacter Pylori Infection Treatment Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Bismuth-quadruple Therapy Table 3. Key Players of Concomitant Therapy Table 4. Key Players of Levofloxacin Triple Therapy Table 3. Key Players of Bismuth Therapy Table 4. Key Players of High-dose Dual Therapy Table 5. Global Helicobacter Pylori Infection Treatment Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 6. Key Players of Hospitals Table 7. Key Players of Diagnostics Laboratories Table 8. Key Players of Clinics Table 9. Global Helicobacter Pylori Infection Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Helicobacter Pylori Infection Treatment Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Helicobacter Pylori Infection Treatment Market Share by Region (2021-2026) Table 12. Global Helicobacter Pylori Infection Treatment Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Helicobacter Pylori Infection Treatment Market Share by Region (2027-2032) Table 14. Helicobacter Pylori Infection Treatment Industry Trends Table 15. Helicobacter Pylori Infection Treatment Industry Drivers Table 16. Helicobacter Pylori Infection Treatment Industry Opportunities and Challenges Table 17. Helicobacter Pylori Infection Treatment Industry Restraints Table 18. Global Helicobacter Pylori Infection Treatment Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Helicobacter Pylori Infection Treatment Revenue Market Share by Company (2021-2026) Table 20. Global Helicobacter Pylori Infection Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Helicobacter Pylori Infection Treatment Key Company Head Office and Area Served Table 22. Global Helicobacter Pylori Infection Treatment Company, Product Type & Application Table 23. Global Helicobacter Pylori Infection Treatment Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Helicobacter Pylori Infection Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Helicobacter Pylori Infection Treatment Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Helicobacter Pylori Infection Treatment Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Helicobacter Pylori Infection Treatment Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Helicobacter Pylori Infection Treatment Revenue Market Share by Type (2021-2026) Table 30. Global Helicobacter Pylori Infection Treatment Revenue Market Share by Type (2027-2032) Table 31. Global Helicobacter Pylori Infection Treatment Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Helicobacter Pylori Infection Treatment Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Helicobacter Pylori Infection Treatment Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Helicobacter Pylori Infection Treatment Revenue Market Share by Application (2021-2026) Table 35. Global Helicobacter Pylori Infection Treatment Revenue Market Share by Application (2027-2032) Table 36. Cumberland Pharmaceuticals Company Information Table 37. Cumberland Pharmaceuticals Business Overview Table 38. Cumberland Pharmaceuticals Helicobacter Pylori Infection Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Cumberland Pharmaceuticals Helicobacter Pylori Infection Treatment Product Portfolio Table 40. Cumberland Pharmaceuticals Recent Development Table 41. Eisai Co. Company Information Table 42. Eisai Co. Business Overview Table 43. Eisai Co. Helicobacter Pylori Infection Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Eisai Co. Helicobacter Pylori Infection Treatment Product Portfolio Table 45. Eisai Co. Recent Development Table 46. Bio-Rad Laboratories Company Information Table 47. Bio-Rad Laboratories Business Overview Table 48. Bio-Rad Laboratories Helicobacter Pylori Infection Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Bio-Rad Laboratories Helicobacter Pylori Infection Treatment Product Portfolio Table 50. Bio-Rad Laboratories Recent Development Table 51. F. Hoffmann-La Roche Company Information Table 52. F. Hoffmann-La Roche Business Overview Table 53. F. Hoffmann-La Roche Helicobacter Pylori Infection Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. F. Hoffmann-La Roche Helicobacter Pylori Infection Treatment Product Portfolio Table 55. F. Hoffmann-La Roche Recent Development Table 56. Alpha Laboratories Company Information Table 57. Alpha Laboratories Business Overview Table 58. Alpha Laboratories Helicobacter Pylori Infection Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Alpha Laboratories Helicobacter Pylori Infection Treatment Product Portfolio Table 60. Alpha Laboratories Recent Development Table 61. Biohit Company Information Table 62. Biohit Business Overview Table 63. Biohit Helicobacter Pylori Infection Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Biohit Helicobacter Pylori Infection Treatment Product Portfolio Table 65. Biohit Recent Development Table 66. Phathom Pharmaceuticals Company Information Table 67. Phathom Pharmaceuticals Business Overview Table 68. Phathom Pharmaceuticals Helicobacter Pylori Infection Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Phathom Pharmaceuticals Helicobacter Pylori Infection Treatment Product Portfolio Table 70. Phathom Pharmaceuticals Recent Development Table 71. Redhill Biopharma Company Information Table 72. Redhill Biopharma Business Overview Table 73. Redhill Biopharma Helicobacter Pylori Infection Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Redhill Biopharma Helicobacter Pylori Infection Treatment Product Portfolio Table 75. Redhill Biopharma Recent Development Table 76. Takeda Pharmaceuticals Company Information Table 77. Takeda Pharmaceuticals Business Overview Table 78. Takeda Pharmaceuticals Helicobacter Pylori Infection Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Takeda Pharmaceuticals Helicobacter Pylori Infection Treatment Product Portfolio Table 80. Takeda Pharmaceuticals Recent Development Table 81. AbbVie Company Information Table 82. AbbVie Business Overview Table 83. AbbVie Helicobacter Pylori Infection Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. AbbVie Helicobacter Pylori Infection Treatment Product Portfolio Table 85. AbbVie Recent Development Table 86. North America Helicobacter Pylori Infection Treatment Market Size by Type (2021-2026) & (US$ Million) Table 87. North America Helicobacter Pylori Infection Treatment Market Size by Type (2027-2032) & (US$ Million) Table 88. North America Helicobacter Pylori Infection Treatment Market Size by Application (2021-2026) & (US$ Million) Table 89. North America Helicobacter Pylori Infection Treatment Market Size by Application (2027-2032) & (US$ Million) Table 90. North America Helicobacter Pylori Infection Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 91. North America Helicobacter Pylori Infection Treatment Market Size by Country (2021-2026) Table 92. North America Helicobacter Pylori Infection Treatment Market Size by Country (2027-2032) Table 93. Europe Helicobacter Pylori Infection Treatment Market Size by Type (2021-2026) & (US$ Million) Table 94. Europe Helicobacter Pylori Infection Treatment Market Size by Type (2027-2032) & (US$ Million) Table 95. Europe Helicobacter Pylori Infection Treatment Market Size by Application (2021-2026) & (US$ Million) Table 96. Europe Helicobacter Pylori Infection Treatment Market Size by Application (2027-2032) & (US$ Million) Table 97. Europe Helicobacter Pylori Infection Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 98. Europe Helicobacter Pylori Infection Treatment Market Size by Country (2021-2026) Table 99. Europe Helicobacter Pylori Infection Treatment Market Size by Country (2027-2032) Table 100. China Helicobacter Pylori Infection Treatment Market Size by Type (2021-2026) & (US$ Million) Table 101. China Helicobacter Pylori Infection Treatment Market Size by Type (2027-2032) & (US$ Million) Table 102. China Helicobacter Pylori Infection Treatment Market Size by Application (2021-2026) & (US$ Million) Table 103. China Helicobacter Pylori Infection Treatment Market Size by Application (2027-2032) & (US$ Million) Table 104. Asia Helicobacter Pylori Infection Treatment Market Size by Type (2021-2026) & (US$ Million) Table 105. Asia Helicobacter Pylori Infection Treatment Market Size by Type (2027-2032) & (US$ Million) Table 106. Asia Helicobacter Pylori Infection Treatment Market Size by Application (2021-2026) & (US$ Million) Table 107. Asia Helicobacter Pylori Infection Treatment Market Size by Application (2027-2032) & (US$ Million) Table 108. Asia Helicobacter Pylori Infection Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 109. Asia Helicobacter Pylori Infection Treatment Market Size by Country (2021-2026) Table 110. Asia Helicobacter Pylori Infection Treatment Market Size by Country (2027-2032) Table 111. South America, Middle East & Africa Helicobacter Pylori Infection Treatment Market Size by Type (2021-2026) & (US$ Million) Table 112. South America, Middle East & Africa Helicobacter Pylori Infection Treatment Market Size by Type (2027-2032) & (US$ Million) Table 113. South America, Middle East & Africa Helicobacter Pylori Infection Treatment Market Size by Application (2021-2026) & (US$ Million) Table 114. South America, Middle East & Africa Helicobacter Pylori Infection Treatment Market Size by Application (2027-2032) & (US$ Million) Table 115. South America, Middle East & Africa Helicobacter Pylori Infection Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. South America, Middle East & Africa Helicobacter Pylori Infection Treatment Market Size by Country (2021-2026) Table 117. South America, Middle East & Africa Helicobacter Pylori Infection Treatment Market Size by Country (2027-2032) Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Helicobacter Pylori Infection Treatment Product Image Figure 2. Global Helicobacter Pylori Infection Treatment Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Helicobacter Pylori Infection Treatment Market Share by Type: 2025 VS 2032 Figure 4. Bismuth-quadruple Therapy Image Figure 5. Concomitant Therapy Image Figure 6. Levofloxacin Triple Therapy Image Figure 7. Bismuth Therapy Image Figure 8. High-dose Dual Therapy Image Figure 9. Global Helicobacter Pylori Infection Treatment Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 10. Global Helicobacter Pylori Infection Treatment Market Share by Application: 2025 VS 2032 Figure 11. Hospitals Image Figure 12. Diagnostics Laboratories Image Figure 13. Clinics Image Figure 14. Global Helicobacter Pylori Infection Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Helicobacter Pylori Infection Treatment Market Size (2021-2032) & (US$ Million) Figure 16. Global Helicobacter Pylori Infection Treatment Market Share by Region: 2025 VS 2032 Figure 17. Years Considered Figure 18. Global Helicobacter Pylori Infection Treatment Market Share by Players in 2025 Figure 19. Global Top 5 and 10 Helicobacter Pylori Infection Treatment Players Market Share by Revenue in 2025 Figure 20. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Helicobacter Pylori Infection Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Helicobacter Pylori Infection Treatment Revenue Market Share by Type (2021-2032) Figure 23. Global Helicobacter Pylori Infection Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Helicobacter Pylori Infection Treatment Revenue Market Share by Application (2021-2032) Figure 25. North America Helicobacter Pylori Infection Treatment Market Size (2021-2032) & (US$ Million) Figure 26. North America Helicobacter Pylori Infection Treatment Market Share by Type (2021-2032) Figure 27. North America Helicobacter Pylori Infection Treatment Market Share by Application (2021-2032) Figure 28. North America Helicobacter Pylori Infection Treatment Market Share by Country (2021-2032) Figure 29. United States Helicobacter Pylori Infection Treatment Market Size (2021-2032) & (US$ Million) Figure 30. Canada Helicobacter Pylori Infection Treatment Market Size (2021-2032) & (US$ Million) Figure 31. Mexico Helicobacter Pylori Infection Treatment Market Size (2021-2032) & (US$ Million) Figure 32. Europe Helicobacter Pylori Infection Treatment Market Size (2021-2032) & (US$ Million) Figure 33. Europe Helicobacter Pylori Infection Treatment Market Share by Type (2021-2032) Figure 34. Europe Helicobacter Pylori Infection Treatment Market Share by Application (2021-2032) Figure 35. Europe Helicobacter Pylori Infection Treatment Market Share by Country (2021-2032) Figure 36. Germany Helicobacter Pylori Infection Treatment Market Size (2021-2032) & (US$ Million) Figure 37. France Helicobacter Pylori Infection Treatment Market Size (2021-2032) & (US$ Million) Figure 38. U.K. Helicobacter Pylori Infection Treatment Market Size (2021-2032) & (US$ Million) Figure 39. Italy Helicobacter Pylori Infection Treatment Market Size (2021-2032) & (US$ Million) Figure 40. Russia Helicobacter Pylori Infection Treatment Market Size (2021-2032) & (US$ Million) Figure 41. Nordic Countries Helicobacter Pylori Infection Treatment Market Size (2021-2032) & (US$ Million) Figure 42. China Helicobacter Pylori Infection Treatment Market Size (2021-2032) & (US$ Million) Figure 43. China Helicobacter Pylori Infection Treatment Market Share by Type (2021-2032) Figure 44. China Helicobacter Pylori Infection Treatment Market Share by Application (2021-2032) Figure 45. Asia Helicobacter Pylori Infection Treatment Market Size (2021-2032) & (US$ Million) Figure 46. Asia Helicobacter Pylori Infection Treatment Market Share by Type (2021-2032) Figure 47. Asia Helicobacter Pylori Infection Treatment Market Share by Application (2021-2032) Figure 48. Asia Helicobacter Pylori Infection Treatment Market Share by Country (2021-2032) Figure 49. Japan Helicobacter Pylori Infection Treatment Market Size (2021-2032) & (US$ Million) Figure 50. South Korea Helicobacter Pylori Infection Treatment Market Size (2021-2032) & (US$ Million) Figure 51. Taiwan Helicobacter Pylori Infection Treatment Market Size (2021-2032) & (US$ Million) Figure 52. Southeast Asia Helicobacter Pylori Infection Treatment Market Size (2021-2032) & (US$ Million) Figure 53. India Helicobacter Pylori Infection Treatment Market Size (2021-2032) & (US$ Million) Figure 54. Australia Helicobacter Pylori Infection Treatment Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Helicobacter Pylori Infection Treatment Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Helicobacter Pylori Infection Treatment Market Share by Type (2021-2032) Figure 57. South America, Middle East & Africa Helicobacter Pylori Infection Treatment Market Share by Application (2021-2032) Figure 58. South America, Middle East & Africa Helicobacter Pylori Infection Treatment Market Share by Country (2021-2032) Figure 59. Brazil Helicobacter Pylori Infection Treatment Market Size (2021-2032) & (US$ Million) Figure 60. South Africa Helicobacter Pylori Infection Treatment Market Size (2021-2032) & (US$ Million) Figure 61. Saudi Arabia Helicobacter Pylori Infection Treatment Market Size (2021-2032) & (US$ Million) Figure 62. Turkey Helicobacter Pylori Infection Treatment Market Size (2021-2032) & (US$ Million) Figure 63. Argentina Helicobacter Pylori Infection Treatment Market Size (2021-2032) & (US$ Million) Figure 64. UAE Helicobacter Pylori Infection Treatment Market Size (2021-2032) & (US$ Million) Figure 65. Egypt Helicobacter Pylori Infection Treatment Market Size (2021-2032) & (US$ Million) Figure 66. Chile Helicobacter Pylori Infection Treatment Market Size (2021-2032) & (US$ Million) Figure 67. Research Process Figure 68. Key Executives Interviewed

Scope & coverage.

Types
  • Bismuth-quadruple Therapy
  • Concomitant Therapy
  • Levofloxacin Triple Therapy
  • Bismuth Therapy
  • High-dose Dual Therapy
Applications
  • Hospitals
  • Diagnostics Laboratories
  • Clinics
Companies covered
  • Cumberland Pharmaceuticals
  • Eisai Co.
  • Bio-Rad Laboratories
  • F. Hoffmann-La Roche
  • Alpha Laboratories
  • Biohit
  • Phathom Pharmaceuticals
  • Redhill Biopharma
  • Takeda Pharmaceuticals
  • AbbVie

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Helicobacter Pylori Infection Treatment Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Bismuth-quadruple Therapy
  5. 1.2.3 Concomitant Therapy
  6. 1.2.4 Levofloxacin Triple Therapy
  7. 1.2.5 Bismuth Therapy
  8. 1.2.6 High-dose Dual Therapy
  9. 1.3 Market Analysis by Application
  10. 1.3.1 Global Helicobacter Pylori Infection Treatment Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  11. 1.3.2 Hospitals
  12. 1.3.3 Diagnostics Laboratories
  13. 1.3.4 Clinics
  14. 1.4 Global Market Growth Prospects
  15. 1.5 Global Helicobacter Pylori Infection Treatment Growth Trends by Region
  16. 1.5.1 Global Helicobacter Pylori Infection Treatment Market Size by Region: 2021 VS 2025 VS 2032
  17. 1.5.2 Helicobacter Pylori Infection Treatment Market Size by Region (2021-2026)
  18. 1.5.3 Helicobacter Pylori Infection Treatment Market Size by Region (2027-2032)
  19. 1.6 Assumptions and Limitations
  20. 1.7 Study Goals and Objectives
  21. 1.8 Years Considered
2 Global Helicobacter Pylori Infection Treatment Market Dynamics
  1. 2.1 Helicobacter Pylori Infection Treatment Industry Trends
  2. 2.2 Helicobacter Pylori Infection Treatment Industry Drivers
  3. 2.3 Helicobacter Pylori Infection Treatment Industry Opportunities and Challenges
  4. 2.4 Helicobacter Pylori Infection Treatment Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Helicobacter Pylori Infection Treatment Revenue by Company (2021-2026)
  2. 3.2 Global Helicobacter Pylori Infection Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Helicobacter Pylori Infection Treatment Key Company Head office and Area Served
  4. 3.4 Global Helicobacter Pylori Infection Treatment Company, Product Type & Application
  5. 3.5 Global Helicobacter Pylori Infection Treatment Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Helicobacter Pylori Infection Treatment Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Helicobacter Pylori Infection Treatment Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Helicobacter Pylori Infection Treatment Tier 1, Tier 2, and Tier 3
4 Helicobacter Pylori Infection Treatment Market by Type
  1. 4.1 Global Helicobacter Pylori Infection Treatment Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Helicobacter Pylori Infection Treatment Market Size by Type (2021-2032)
  3. 4.3 Global Helicobacter Pylori Infection Treatment Market Size Share by Type (2021-2032)
5 Helicobacter Pylori Infection Treatment Market by Application
  1. 5.1 Global Helicobacter Pylori Infection Treatment Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Helicobacter Pylori Infection Treatment Market Size by Application (2021-2032)
  3. 5.3 Global Helicobacter Pylori Infection Treatment Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Cumberland Pharmaceuticals
  2. 6.1.1 Cumberland Pharmaceuticals Company Information
  3. 6.1.2 Cumberland Pharmaceuticals Business Overview
  4. 6.1.3 Cumberland Pharmaceuticals Helicobacter Pylori Infection Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Cumberland Pharmaceuticals Helicobacter Pylori Infection Treatment Product Portfolio
  6. 6.1.5 Cumberland Pharmaceuticals Recent Developments
  7. 6.2 Eisai Co.
  8. 6.2.1 Eisai Co. Company Information
  9. 6.2.2 Eisai Co. Business Overview
  10. 6.2.3 Eisai Co. Helicobacter Pylori Infection Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Eisai Co. Helicobacter Pylori Infection Treatment Product Portfolio
  12. 6.2.5 Eisai Co. Recent Developments
  13. 6.3 Bio-Rad Laboratories
  14. 6.3.1 Bio-Rad Laboratories Company Information
  15. 6.3.2 Bio-Rad Laboratories Business Overview
  16. 6.3.3 Bio-Rad Laboratories Helicobacter Pylori Infection Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Bio-Rad Laboratories Helicobacter Pylori Infection Treatment Product Portfolio
  18. 6.3.5 Bio-Rad Laboratories Recent Developments
  19. 6.4 F. Hoffmann-La Roche
  20. 6.4.1 F. Hoffmann-La Roche Company Information
  21. 6.4.2 F. Hoffmann-La Roche Business Overview
  22. 6.4.3 F. Hoffmann-La Roche Helicobacter Pylori Infection Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 F. Hoffmann-La Roche Helicobacter Pylori Infection Treatment Product Portfolio
  24. 6.4.5 F. Hoffmann-La Roche Recent Developments
  25. 6.5 Alpha Laboratories
  26. 6.5.1 Alpha Laboratories Company Information
  27. 6.5.2 Alpha Laboratories Business Overview
  28. 6.5.3 Alpha Laboratories Helicobacter Pylori Infection Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Alpha Laboratories Helicobacter Pylori Infection Treatment Product Portfolio
  30. 6.5.5 Alpha Laboratories Recent Developments
  31. 6.6 Biohit
  32. 6.6.1 Biohit Company Information
  33. 6.6.2 Biohit Business Overview
  34. 6.6.3 Biohit Helicobacter Pylori Infection Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Biohit Helicobacter Pylori Infection Treatment Product Portfolio
  36. 6.6.5 Biohit Recent Developments
  37. 6.7 Phathom Pharmaceuticals
  38. 6.7.1 Phathom Pharmaceuticals Company Information
  39. 6.7.2 Phathom Pharmaceuticals Business Overview
  40. 6.7.3 Phathom Pharmaceuticals Helicobacter Pylori Infection Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Phathom Pharmaceuticals Helicobacter Pylori Infection Treatment Product Portfolio
  42. 6.7.5 Phathom Pharmaceuticals Recent Developments
  43. 6.8 Redhill Biopharma
  44. 6.8.1 Redhill Biopharma Company Information
  45. 6.8.2 Redhill Biopharma Business Overview
  46. 6.8.3 Redhill Biopharma Helicobacter Pylori Infection Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Redhill Biopharma Helicobacter Pylori Infection Treatment Product Portfolio
  48. 6.8.5 Redhill Biopharma Recent Developments
  49. 6.9 Takeda Pharmaceuticals
  50. 6.9.1 Takeda Pharmaceuticals Company Information
  51. 6.9.2 Takeda Pharmaceuticals Business Overview
  52. 6.9.3 Takeda Pharmaceuticals Helicobacter Pylori Infection Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Takeda Pharmaceuticals Helicobacter Pylori Infection Treatment Product Portfolio
  54. 6.9.5 Takeda Pharmaceuticals Recent Developments
  55. 6.10 AbbVie
  56. 6.10.1 AbbVie Company Information
  57. 6.10.2 AbbVie Business Overview
  58. 6.10.3 AbbVie Helicobacter Pylori Infection Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 AbbVie Helicobacter Pylori Infection Treatment Product Portfolio
  60. 6.10.5 AbbVie Recent Developments
7 North America
  1. 7.1 North America Helicobacter Pylori Infection Treatment Market Size (2021-2032)
  2. 7.2 North America Helicobacter Pylori Infection Treatment Market Size by Type
  3. 7.2.1 North America Helicobacter Pylori Infection Treatment Market Size by Type (2021-2026)
  4. 7.2.2 North America Helicobacter Pylori Infection Treatment Market Size by Type (2027-2032)
  5. 7.2.3 North America Helicobacter Pylori Infection Treatment Market Share by Type (2021-2032)
  6. 7.3 North America Helicobacter Pylori Infection Treatment Market Size by Application
  7. 7.3.1 North America Helicobacter Pylori Infection Treatment Market Size by Application (2021-2026)
  8. 7.3.2 North America Helicobacter Pylori Infection Treatment Market Size by Application (2027-2032)
  9. 7.3.3 North America Helicobacter Pylori Infection Treatment Market Share by Application (2021-2032)
  10. 7.4 North America Helicobacter Pylori Infection Treatment Market Size by Country
  11. 7.4.1 North America Helicobacter Pylori Infection Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Helicobacter Pylori Infection Treatment Market Size by Country (2021-2026)
  13. 7.4.3 North America Helicobacter Pylori Infection Treatment Market Size by Country (2027-2032)
  14. 7.4.4 North America Helicobacter Pylori Infection Treatment Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Helicobacter Pylori Infection Treatment Market Size (2021-2032)
  2. 8.2 Europe Helicobacter Pylori Infection Treatment Market Size by Type
  3. 8.2.1 Europe Helicobacter Pylori Infection Treatment Market Size by Type (2021-2026)
  4. 8.2.2 Europe Helicobacter Pylori Infection Treatment Market Size by Type (2027-2032)
  5. 8.2.3 Europe Helicobacter Pylori Infection Treatment Market Share by Type (2021-2032)
  6. 8.3 Europe Helicobacter Pylori Infection Treatment Market Size by Application
  7. 8.3.1 Europe Helicobacter Pylori Infection Treatment Market Size by Application (2021-2026)
  8. 8.3.2 Europe Helicobacter Pylori Infection Treatment Market Size by Application (2027-2032)
  9. 8.3.3 Europe Helicobacter Pylori Infection Treatment Market Share by Application (2021-2032)
  10. 8.4 Europe Helicobacter Pylori Infection Treatment Market Size by Country
  11. 8.4.1 Europe Helicobacter Pylori Infection Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Helicobacter Pylori Infection Treatment Market Size by Country (2021-2026)
  13. 8.4.3 Europe Helicobacter Pylori Infection Treatment Market Size by Country (2027-2032)
  14. 8.4.4 Europe Helicobacter Pylori Infection Treatment Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Helicobacter Pylori Infection Treatment Market Size (2021-2032)
  2. 9.2 China Helicobacter Pylori Infection Treatment Market Size by Type
  3. 9.2.1 China Helicobacter Pylori Infection Treatment Market Size by Type (2021-2026)
  4. 9.2.2 China Helicobacter Pylori Infection Treatment Market Size by Type (2027-2032)
  5. 9.2.3 China Helicobacter Pylori Infection Treatment Market Share by Type (2021-2032)
  6. 9.3 China Helicobacter Pylori Infection Treatment Market Size by Application
  7. 9.3.1 China Helicobacter Pylori Infection Treatment Market Size by Application (2021-2026)
  8. 9.3.2 China Helicobacter Pylori Infection Treatment Market Size by Application (2027-2032)
  9. 9.3.3 China Helicobacter Pylori Infection Treatment Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Helicobacter Pylori Infection Treatment Market Size (2021-2032)
  2. 10.2 Asia Helicobacter Pylori Infection Treatment Market Size by Type
  3. 10.2.1 Asia Helicobacter Pylori Infection Treatment Market Size by Type (2021-2026)
  4. 10.2.2 Asia Helicobacter Pylori Infection Treatment Market Size by Type (2027-2032)
  5. 10.2.3 Asia Helicobacter Pylori Infection Treatment Market Share by Type (2021-2032)
  6. 10.3 Asia Helicobacter Pylori Infection Treatment Market Size by Application
  7. 10.3.1 Asia Helicobacter Pylori Infection Treatment Market Size by Application (2021-2026)
  8. 10.3.2 Asia Helicobacter Pylori Infection Treatment Market Size by Application (2027-2032)
  9. 10.3.3 Asia Helicobacter Pylori Infection Treatment Market Share by Application (2021-2032)
  10. 10.4 Asia Helicobacter Pylori Infection Treatment Market Size by Country
  11. 10.4.1 Asia Helicobacter Pylori Infection Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Helicobacter Pylori Infection Treatment Market Size by Country (2021-2026)
  13. 10.4.3 Asia Helicobacter Pylori Infection Treatment Market Size by Country (2027-2032)
  14. 10.4.4 Asia Helicobacter Pylori Infection Treatment Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Helicobacter Pylori Infection Treatment Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Helicobacter Pylori Infection Treatment Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Helicobacter Pylori Infection Treatment Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Helicobacter Pylori Infection Treatment Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Helicobacter Pylori Infection Treatment Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Helicobacter Pylori Infection Treatment Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Helicobacter Pylori Infection Treatment Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Helicobacter Pylori Infection Treatment Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Helicobacter Pylori Infection Treatment Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Helicobacter Pylori Infection Treatment Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Helicobacter Pylori Infection Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Helicobacter Pylori Infection Treatment Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Helicobacter Pylori Infection Treatment Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Helicobacter Pylori Infection Treatment Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst